JP2011508773A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011508773A5 JP2011508773A5 JP2010541427A JP2010541427A JP2011508773A5 JP 2011508773 A5 JP2011508773 A5 JP 2011508773A5 JP 2010541427 A JP2010541427 A JP 2010541427A JP 2010541427 A JP2010541427 A JP 2010541427A JP 2011508773 A5 JP2011508773 A5 JP 2011508773A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- animal
- composition according
- norc
- ufa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 claims 12
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims 8
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims 8
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 6
- 230000003920 cognitive function Effects 0.000 claims 6
- 230000007423 decrease Effects 0.000 claims 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims 2
- 229930003270 Vitamin B Natural products 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 230000001149 cognitive effect Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 2
- 230000006870 function Effects 0.000 claims 2
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 claims 2
- 235000019156 vitamin B Nutrition 0.000 claims 2
- 239000011720 vitamin B Substances 0.000 claims 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims 1
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 claims 1
- 208000000044 Amnesia Diseases 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 102000055006 Calcitonin Human genes 0.000 claims 1
- 108060001064 Calcitonin Proteins 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 208000022540 Consciousness disease Diseases 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 241000218628 Ginkgo Species 0.000 claims 1
- 235000011201 Ginkgo Nutrition 0.000 claims 1
- 244000194101 Ginkgo biloba Species 0.000 claims 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 1
- YSEXMKHXIOCEJA-FVFQAYNVSA-N Nicergoline Chemical compound C([C@@H]1C[C@]2([C@H](N(C)C1)CC=1C3=C2C=CC=C3N(C)C=1)OC)OC(=O)C1=CN=CC(Br)=C1 YSEXMKHXIOCEJA-FVFQAYNVSA-N 0.000 claims 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 1
- RBQOQRRFDPXAGN-UHFFFAOYSA-N Propentofylline Chemical compound CN1C(=O)N(CCCCC(C)=O)C(=O)C2=C1N=CN2CCC RBQOQRRFDPXAGN-UHFFFAOYSA-N 0.000 claims 1
- IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 claims 1
- DDNCQMVWWZOMLN-IRLDBZIGSA-N Vinpocetine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(=O)OCC)N5C2=C1 DDNCQMVWWZOMLN-IRLDBZIGSA-N 0.000 claims 1
- 229940062527 alendronate Drugs 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 229960003121 arginine Drugs 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 230000037147 athletic performance Effects 0.000 claims 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims 1
- 229960004015 calcitonin Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960002173 citrulline Drugs 0.000 claims 1
- 235000013477 citrulline Nutrition 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 229960003530 donepezil Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000262 estrogen Substances 0.000 claims 1
- 229940011871 estrogen Drugs 0.000 claims 1
- 235000021323 fish oil Nutrition 0.000 claims 1
- 229960003980 galantamine Drugs 0.000 claims 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 claims 1
- 229960003642 nicergoline Drugs 0.000 claims 1
- 239000002840 nitric oxide donor Substances 0.000 claims 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 1
- 229960003104 ornithine Drugs 0.000 claims 1
- 239000003075 phytoestrogen Substances 0.000 claims 1
- 229960002934 propentofylline Drugs 0.000 claims 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 claims 1
- 229960004622 raloxifene Drugs 0.000 claims 1
- 229940089617 risedronate Drugs 0.000 claims 1
- MEZLKOACVSPNER-GFCCVEGCSA-N selegiline Chemical compound C#CCN(C)[C@H](C)CC1=CC=CC=C1 MEZLKOACVSPNER-GFCCVEGCSA-N 0.000 claims 1
- 229960003946 selegiline Drugs 0.000 claims 1
- 229960000744 vinpocetine Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1009708P | 2008-01-04 | 2008-01-04 | |
| US61/010,097 | 2008-01-04 | ||
| US13738208P | 2008-07-30 | 2008-07-30 | |
| US61/137,382 | 2008-07-30 | ||
| PCT/US2008/013870 WO2009088433A1 (en) | 2008-01-04 | 2008-12-19 | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011508773A JP2011508773A (ja) | 2011-03-17 |
| JP2011508773A5 true JP2011508773A5 (cg-RX-API-DMAC7.html) | 2012-02-09 |
| JP5979816B2 JP5979816B2 (ja) | 2016-08-31 |
Family
ID=40853324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010541427A Active JP5979816B2 (ja) | 2008-01-04 | 2008-12-19 | 不飽和脂肪酸及び酸化窒素放出化合物を含む組成物、並びに認知機能及び関連の機能を高めるためのそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20100233304A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2224930B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5979816B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101909632A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008347177B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0822238B8 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2994586C (cg-RX-API-DMAC7.html) |
| ES (2) | ES2773928T5 (cg-RX-API-DMAC7.html) |
| MX (1) | MX337760B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2500402C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009088433A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8252742B2 (en) * | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| CA2912259C (en) | 2005-05-27 | 2020-04-28 | Mark H. Schoenfisch | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| HUE037628T2 (hu) * | 2007-10-04 | 2018-09-28 | Nestec Sa | Készítmények és eljárások kognitív funkció javítására |
| CA2731088C (en) * | 2008-07-18 | 2015-09-22 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| AU2013200758B2 (en) * | 2008-07-18 | 2014-06-12 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| CA2771389C (en) | 2009-08-21 | 2019-04-09 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
| ES2958410T3 (es) | 2009-08-21 | 2024-02-08 | Novan Inc | Geles tópicos |
| CA2773523A1 (en) * | 2009-09-11 | 2011-03-17 | Nestec S.A. | Compositions and methods for enhancing cognitive and related functions in animals |
| WO2011081509A1 (es) * | 2009-12-29 | 2011-07-07 | Chavez Gabriela | Composiciones nutricionales que comprenden hojuelas de frutas que incluyen ácido docosahexaenoico |
| US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
| CN102552457A (zh) * | 2010-12-24 | 2012-07-11 | 漆又毛 | 一种氨基酸和提取物组合物的药物用途 |
| EP2667882B1 (en) * | 2011-01-25 | 2020-08-12 | Société des Produits Nestlé S.A. | Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals |
| EP2675447A4 (en) | 2011-02-18 | 2015-04-22 | Nestec Sa | METHODS AND COMPOSITIONS FOR TREATING, REDUCING OR PREVENTING DAMAGE TO THE NERVOUS ANIMAL SYSTEM |
| ES2695173T3 (es) | 2011-02-28 | 2019-01-02 | Novan Inc | Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas |
| BR112013023770B1 (pt) * | 2011-03-18 | 2020-12-15 | Société des Produits Nestlé S.A. | Composição útil para aliviar distúrbios relacionados à idade em um animal, e seu uso |
| AT511776B1 (de) * | 2011-07-26 | 2014-03-15 | Gonadosan Gmbh | Verwendung von citrullin und ein kombinationspräparat zur verbesserung der männlichen fertilität |
| US20130059028A1 (en) * | 2011-09-01 | 2013-03-07 | Julie Marie Foy | Compositions and Methods for Providing a Life-Stage-Appropriate Animal Diet |
| CN102600124B (zh) * | 2012-02-06 | 2014-03-26 | 单宝华 | Omega-3增强组合物及其应用 |
| US10369186B2 (en) * | 2012-10-30 | 2019-08-06 | Kyowa Hakko Bio Co., Ltd. | Method of treating decline in brain function comprising coadministration of citrulline and glutathione |
| US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
| US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
| CN103609752B (zh) * | 2013-12-02 | 2016-05-25 | 内蒙古伊利实业集团股份有限公司 | 一种改善脑部认知功能的组合物及其制备方法与应用 |
| JP2017502283A (ja) * | 2013-12-19 | 2017-01-19 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 高タンパク質食品の腐敗を決定するための方法 |
| WO2015160234A1 (en) * | 2014-04-17 | 2015-10-22 | N.V. Nutricia | Composition for brain improvement |
| CA2963350A1 (en) * | 2014-10-10 | 2016-04-14 | Nestec S.A. | Compositions and methods for enhancing mobility or activity or treating frailty |
| EP3215143B1 (en) * | 2014-10-22 | 2021-07-21 | Again Life Italia Srl | Combination comprising spirulina and palmitoylethanolamide |
| MX389716B (es) * | 2014-12-29 | 2025-03-11 | Hills Pet Nutrition Inc | Composición de alimentos y método de uso. |
| EP3310349B1 (en) | 2015-06-22 | 2021-01-13 | Société des Produits Nestlé S.A. | Compositions and methods for enhancing neurogenesis in animals |
| CN105602998A (zh) * | 2016-01-18 | 2016-05-25 | 青岛哈拿生物科技有限公司 | 一种水溶性天然一氧化氮的制作方法及应用 |
| CA3024365A1 (en) * | 2016-05-27 | 2017-11-30 | Nestec S.A. | Nutritional composition for treating or preventing impaired mobility |
| JP7523905B2 (ja) * | 2016-09-29 | 2024-07-29 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 認知症でない患者における神経保護薬としての、ω３脂肪酸、一酸化窒素放出化合物及びビタミンＢ１２ |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| WO2018175259A1 (en) * | 2017-03-18 | 2018-09-27 | Mcgarrah Steven M | Pet food including cannabidiolic acid |
| AU2017408873A1 (en) * | 2017-04-11 | 2019-08-29 | Societe Des Produits Nestle S.A. | Omega-3 fatty acid and vitamin D levels to identify and attenuate cognitive aging in individuals |
| CN111295187A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗肝脏疾病的氨基酸组合物 |
| AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
| JPWO2022191184A1 (cg-RX-API-DMAC7.html) * | 2021-03-08 | 2022-09-15 | ||
| EP4449875A1 (en) | 2023-04-18 | 2024-10-23 | Mars, Incorporated | Composition for use for improving or preserving mental health in canine |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2018A (en) * | 1841-03-26 | Joseph francis | ||
| US6294520B1 (en) | 1989-03-27 | 2001-09-25 | Albert T. Naito | Material for passage through the blood-brain barrier |
| GB2268871A (en) * | 1992-07-04 | 1994-01-26 | Bio Nutritional Health Service | Composition for use as a food or food supplement |
| IT1264987B1 (it) * | 1993-12-14 | 1996-10-17 | Prospa Bv | Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono |
| FI972744L (fi) | 1995-02-23 | 1997-08-22 | Novartis Nutrition Ag | Aminohappokokoonpanoja ja niiden käyttö kliinisessä ravinnossa |
| CA2185983C (en) | 1996-09-19 | 2004-04-13 | Wie-Jong Kwak | Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| US5874471A (en) * | 1997-02-27 | 1999-02-23 | Waugh; William Howard | Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection |
| US7135498B1 (en) * | 1999-06-14 | 2006-11-14 | Henry Ford Health System | Nitric oxide donors for inducing neurogenesis |
| ATE408402T1 (de) * | 1999-06-14 | 2008-10-15 | Ford Henry Health System | Stickstoffmonoxid-donoren zum induzieren von neurogenese |
| JP4669095B2 (ja) | 1999-07-19 | 2011-04-13 | 太陽化学株式会社 | ペットの問題行動抑制組成物 |
| US20040043013A1 (en) * | 2000-12-28 | 2004-03-04 | Mccleary Edward Larry | Metabolic uncoupling therapy |
| US20050002992A1 (en) | 2003-06-17 | 2005-01-06 | Mccleary Edward Larry | Foods, beverages, condiments, spices and salad dressings with specialized supplements |
| JP4304982B2 (ja) * | 2001-03-23 | 2009-07-29 | 味の素株式会社 | 抗ストレス性疾患剤 |
| US6964969B2 (en) * | 2001-04-19 | 2005-11-15 | Mccleary Edward Larry | Composition and method for treating impaired or deteriorating neurological function |
| US20060014773A1 (en) * | 2001-04-19 | 2006-01-19 | Mccleary Edward L | Mental agility lozenge, edible strip, food or drink |
| DE10131516B4 (de) | 2001-07-02 | 2004-05-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Steuereinheit zur Flussregulierung |
| AU2002336638A1 (en) * | 2001-10-12 | 2003-04-28 | Cornell Research Foundation, Inc. | Reversing or preventing premature vascular senescence |
| NL1019368C2 (nl) | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| US7514107B2 (en) * | 2002-03-21 | 2009-04-07 | Mars, Incorporated | Treatment of diseases involving defective gap junctional communication |
| US20040001817A1 (en) † | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
| US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| CN100415224C (zh) | 2003-03-18 | 2008-09-03 | 诺瓦提斯公司 | 包含脂肪酸和氨基酸的组合物 |
| WO2005006877A1 (en) | 2003-07-03 | 2005-01-27 | Hill's Pet Nutrition, Inc. | Compositions and methods for decreasing age-related deterioration in metal activities in companion animals |
| US6951658B1 (en) | 2003-07-08 | 2005-10-04 | Pearson Research & Development Limited | Emu-based compositions for mental well-being and method of use |
| US20060280776A1 (en) * | 2003-09-02 | 2006-12-14 | Masafumi Koide | Diet food |
| CA2549429A1 (en) | 2003-12-22 | 2005-07-07 | Wakunaga Pharmaceutical Co., Ltd. | Fat composition |
| US20060002985A1 (en) | 2004-07-02 | 2006-01-05 | Zicker Steven C | Compositions and methods for decreasing age-related deterioration in mental activities in companion animals |
| EP1634599A1 (en) * | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
| ES2436181T3 (es) | 2004-12-29 | 2013-12-27 | Hill's Pet Nutrition Inc. | Métodos para inhibir un declive en el aprendizaje y/o la memoria en animales |
| BRPI0519610A2 (pt) | 2004-12-30 | 2009-02-25 | Hills Pet Nutrition Inc | mÉtodos para melhorar a qualidade de vida de um animal idoso ou muito idoso, de um canino de raÇa regular ou pequena, idoso ou muito idoso, de um cço de raÇa grande idoso ou muito idoso, e de um gato idoso ou muito idoso |
| EP2762007B1 (en) | 2004-12-30 | 2016-11-02 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a growing animal |
| US8324276B2 (en) * | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
| CN1810257A (zh) * | 2005-05-26 | 2006-08-02 | 钟健琳 | 活脑素口服液 |
| CN101981586A (zh) | 2005-06-30 | 2011-02-23 | 皇家飞利浦电子股份有限公司 | 用于选择信息的方法和系统 |
| ES2617577T3 (es) | 2005-07-08 | 2017-06-19 | Dsm Ip Assets B.V. | Ácidos grasos poliinsaturados para el tratamiento de la demencia y afecciones relacionadas con la pre-demencia |
| CA2620024C (en) * | 2005-08-26 | 2014-11-18 | Nestec S.A. | Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
| RU2413427C2 (ru) | 2005-09-30 | 2011-03-10 | Нестек С.А. | Способы и композиция для улучшения когнитивной функции |
| EP1955698B1 (en) | 2005-12-02 | 2013-10-30 | Mochida Pharmaceutical Co., Ltd. | Preventive/therapeutic agent for alzheimer's dementia |
| DK1800675T3 (da) | 2005-12-23 | 2011-09-05 | Nutricia Nv | Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens |
| HUE035852T2 (en) * | 2006-04-03 | 2018-05-28 | Accera Inc | Use of ketogen compounds to treat memory decline |
| HUE037628T2 (hu) | 2007-10-04 | 2018-09-28 | Nestec Sa | Készítmények és eljárások kognitív funkció javítására |
| WO2014100896A1 (en) | 2012-12-31 | 2014-07-03 | Aastra Technologies Limited | Interface adapter |
-
2008
- 2008-12-19 RU RU2010132637/15A patent/RU2500402C2/ru active
- 2008-12-19 JP JP2010541427A patent/JP5979816B2/ja active Active
- 2008-12-19 US US12/734,013 patent/US20100233304A1/en not_active Abandoned
- 2008-12-19 EP EP08869735.4A patent/EP2224930B1/en active Active
- 2008-12-19 EP EP16163261.7A patent/EP3058942B2/en active Active
- 2008-12-19 CA CA2994586A patent/CA2994586C/en active Active
- 2008-12-19 BR BRPI0822238A patent/BRPI0822238B8/pt active IP Right Grant
- 2008-12-19 WO PCT/US2008/013870 patent/WO2009088433A1/en not_active Ceased
- 2008-12-19 ES ES16163261T patent/ES2773928T5/es active Active
- 2008-12-19 AU AU2008347177A patent/AU2008347177B2/en active Active
- 2008-12-19 CA CA2709660A patent/CA2709660C/en active Active
- 2008-12-19 CN CN200880123505XA patent/CN101909632A/zh active Pending
- 2008-12-19 CN CN201510779748.0A patent/CN105267969A/zh active Pending
- 2008-12-19 ES ES08869735.4T patent/ES2586757T3/es active Active
- 2008-12-19 MX MX2010007438A patent/MX337760B/es active IP Right Grant
-
2017
- 2017-02-23 US US15/440,702 patent/US10111911B2/en active Active
-
2018
- 2018-10-03 US US16/150,979 patent/US10973859B2/en active Active
-
2021
- 2021-03-19 US US17/206,851 patent/US11951137B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011508773A5 (cg-RX-API-DMAC7.html) | ||
| JP2010540636A5 (cg-RX-API-DMAC7.html) | ||
| RU2010132637A (ru) | Композиции, включающие ненасыщенные жирные кислоты и соединения, высбождающие оксид азота, и их применение для усиления когнитивной функции и связанных с ней функцией | |
| GB2459809A (en) | Fatty acid formulations and methods of use thereof | |
| RU2010117221A (ru) | Композиции и способы усиления когнитивной функции | |
| Engelborghs et al. | Rationale and clinical data supporting nutritional intervention in Alzheimer’s disease | |
| Bendyk et al. | Effect of dietary omega‐3 polyunsaturated fatty acids on experimental periodontitis in the mouse | |
| JP2014505702A5 (cg-RX-API-DMAC7.html) | ||
| BRPI0516718A (pt) | forma de dosagem de ibuprofeno de liberação modificada | |
| BR112012019374A2 (pt) | composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo | |
| JP2014514248A5 (cg-RX-API-DMAC7.html) | ||
| JP2015510888A5 (cg-RX-API-DMAC7.html) | ||
| SG10201400685SA (en) | Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia | |
| Zarif Najafi et al. | Comparison of the effects of preemptive acetaminophen, ibuprofen, and meloxicam on pain after separator placement: a randomized clinical trial | |
| HRP20110453T1 (hr) | Sastav peleta lipoične kiseline | |
| MX379147B (es) | Composiciones y métodos para mejorar la neurogénesis en animales. | |
| MX2021015377A (es) | Acidos grasos omega 3 y colina como neuroprotectores en pacientes sin demencia. | |
| FR2902007B1 (fr) | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s) ainsi que leurs applications notamment therapeutiques | |
| JP2017186335A (ja) | アミロイドβ凝集阻害剤 | |
| BR112014014130A2 (pt) | tratamento ou redução de condições dentárias com ésteres de ascorbilo | |
| RU2016129079A (ru) | Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы | |
| ATE443515T1 (de) | Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung | |
| Zouboulis et al. | Retinoids | |
| MA27669A1 (fr) | Formulations topiques stabilisees contenant du ketoprofene | |
| WO2012075093A3 (en) | Topical formulations for administration of omega-3 fatty acids |